Resource Use and Care Quality Differences Among Medicare Beneficiaries Undergoing Chemotherapy.

ABSTRACT:

Importance

Medicare Advantage (MA) has grown significantly over the last decade; however, MA's performance for patients with serious conditions, such as cancer, remains unclear.

Objective

To compare resource use and care quality between MA and traditional Medicare (TM) beneficiaries undergoing cancer chemotherapy.

Design, setting, and participants

This cohort study used TM claims and MA encounter records from January 2015 to December 2019. Participants were MA and TM beneficiaries who initiated cancer chemotherapy between January 2016 and December 2019. Inverse probability of treatment weighting balanced characteristics between MA and TM beneficiaries, and regression estimation was used. The analysis was conducted between August 2023 and May 2024.

Exposure

Chem

SUBMITTER: Kalidindi Y 

PROVIDER: S-EPMC11415781 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature